Literature DB >> 14528077

Renal medullary carcinoma: case report and review of the literature.

Wanda G Noguera-Irizarry1, Hanina Hibshoosh, Kyriakos P Papadopoulos.   

Abstract

Renal medullary carcinoma is a recently recognized epithelial malignant tumor arising in the renal parenchyma. The tumor is almost exclusive to young black patients with the sickle cell trait. Most patients present with metastatic disease and have a poor prognosis. An Hispanic woman with renal medullary carcinoma who initially responded to chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin and survived for 12 months is presented. The clinical, histologic, and radiologic features of this tumor are described, and chemotherapeutic regimens used in this disease are detailed. Treatment modalities have proved largely unsuccessful in the setting of advanced disease. Given the shared demographic, clinical, and radiographic features of these patients, awareness and early diagnosis may prove essential in improving survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528077     DOI: 10.1097/01.coc.0000037663.61643.5A

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  7 in total

1.  Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.

Authors:  Olena O Seminog; Oyindamola I Ogunlaja; David Yeates; Michael J Goldacre
Journal:  J R Soc Med       Date:  2016-06-20       Impact factor: 5.344

2.  Total hip arthroplasty: Concerns and precautions in sickle-cell trait.

Authors:  Francesco Pisanu; Marco Pes; Gianfilippo Caggiari; Sebastiano Ortu; Maria Luisa Satta; Veronica Amorese; Carlo Doria
Journal:  J Orthop       Date:  2019-11-27

3.  Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy.

Authors:  Peter H O'Donnell; Ana Jensen; Edwin M Posadas; Julia A Bridge; Anjana V Yeldandi; Ximing J Yang; Walter M Stadler; Hikmat Al-Ahmadie
Journal:  Nat Rev Urol       Date:  2010-02       Impact factor: 14.432

4.  Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT.

Authors:  Amy Neville; Stephen F Hatem
Journal:  Emerg Radiol       Date:  2007-04-04

5.  Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.

Authors:  Jacob S Lipkin; Syed M Rizvi; Zoran Gatalica; Nabeel E Sarwani; Sheldon L Holder; Mathew Kaag; Joseph J Drabick; Monika Joshi
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib.

Authors:  Alex Q Lee; Masami Ijiri; Ryan Rodriguez; Regina Gandour-Edwards; Joyce Lee; Clifford G Tepper; Yueju Li; Laurel Beckett; Kit Lam; Neal Goodwin; Noriko Satake
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

7.  Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.

Authors:  Ali Imran Amjad; Hira Ali; Leonard J Appleman; Jodi Maranchie; Stephen Jackman; Anil Parwani; Rajiv Dhir; Somak Roy; Rahul A Parikh
Journal:  Case Rep Oncol Med       Date:  2014-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.